ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate SYN115 in Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00605553
Recruitment Status : Completed
First Posted : January 31, 2008
Last Update Posted : August 8, 2017
Sponsor:
Information provided by (Responsible Party):
Biotie Therapies Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2009
  Actual Study Completion Date : May 2009
  Certification/Extension First Submitted : December 3, 2009
Publications of Results:
Black KJ, Campbell MC, Dickerson W, Creech ML, Koller JM, Chung SC, Bandak SI: A randomized, double-blind, placebo-controlled cross-over trial of the adenosine 2a antagonist SYN115 in Parkinson disease. Neurology 74(9): A317, 2010.